Neural Therapeutics Inc. (CSE:NURL)

Neural Therapeutics Statistics

Total Valuation

CSE:NURL has a market cap or net worth of CAD 3.37 million. The enterprise value is 3.86 million.

Market Cap	3.37M
Enterprise Value	3.86M

Important Dates

The next estimated earnings date is Friday, November 21, 2025.

Earnings Date	Nov 21, 2025
Ex-Dividend Date	n/a

Share Statistics

CSE:NURL has 168.70 million shares outstanding. The number of shares has increased by 22.59% in one year.

Current Share Class	168.70M
Shares Outstanding	168.70M
Shares Change (YoY)	+22.59%
Shares Change (QoQ)	+19.16%
Owned by Insiders (%)	0.56%
Owned by Institutions (%)	7.16%
Float	167.76M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	-5.69
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-2.74
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.84

Current Ratio	1.84
Quick Ratio	1.70
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-240.22%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	-480.10%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	0.02
200-Day Moving Average	n/a
Relative Strength Index (RSI)	54.08
Average Volume (20 Days)	378,762

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-692,397
Pretax Income	-1.41M
Net Income	-1.41M
EBITDA	n/a
EBIT	-692,397
Earnings Per Share (EPS)	-0.02

Balance Sheet

The company has 251,385 in cash and 736,670 in debt, giving a net cash position of -485,285 or -0.00 per share.

Cash & Cash Equivalents	251,385
Total Debt	736,670
Net Cash	-485,285
Net Cash Per Share	-0.00
Equity (Book Value)	-592,452
Book Value Per Share	-0.01
Working Capital	144,218

Cash Flow

Operating Cash Flow	-305,676
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CSE:NURL does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-22.59%
Shareholder Yield	-22.59%
Earnings Yield	-41.71%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2